Duncan Mckechnie
EVP, Chief Commercial Officer · 8 filings · Latest: Jul 2, 2026
VERTEX PHARMACEUTICALS INC / MA
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
VRTX | Duncan Mckechnie | EVP, Chief Commercial Officer | Jul 2, 2026 | Sale | $519.00 | 1,541 | $799.8K | 11,001 | |
VRTX | McKechnie Duncan | — | Jul 2, 2026 | Proposed Sale | $519.00 | 1,541 | $799.8K | — | |
VRTX | Duncan Mckechnie | EVP, Chief Commercial Officer | Mar 11, 2026 | Sale | $498.42 | 2,633 | $1.3M | 12,489 | |
VRTX | McKechnie Duncan | — | Mar 11, 2026 | Proposed Sale | $498.42 | 2,633 | $1.3M | — | |
VRTX | Duncan Mckechnie | EVP, Chief Commercial Officer | Mar 4, 2026 | Sale | $475.30 | 2,437 | $1.2M | 15,122 | |
VRTX | McKechnie Duncan | — | Mar 4, 2026 | Proposed Sale | $475.30 | 2,437 | $1.2M | — | |
VRTX | Duncan Mckechnie | EVP, Chief Commercial Officer | Feb 25, 2026 | Sale | $487.65 | 4,910 | $2.4M | 17,559 | |
VRTX | McKechnie Duncan | — | Feb 25, 2026 | Proposed Sale | $487.65 | 4,910 | $2.4M | — |